United States Pertuzumab Market Report 2017

October 2017 | 98 pages | ID: U415B513A32PEN
QYResearch

Abstracts

In this report, the United States Pertuzumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pertuzumab in these regions, from 2012 to 2022 (forecast).

United States Pertuzumab market competition by top manufacturers/players, with Pertuzumab sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Pfizer
• Abnova Corporation
• InvivoGen
• Celltrion
• Biocon Limited
• Bio-Techne

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Human Source
• Animal Source

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pertuzumab for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pertuzumab Market Report 2017

1 PERTUZUMAB OVERVIEW

1.1 Product Overview and Scope of Pertuzumab
1.2 Classification of Pertuzumab by Product Category
  1.2.1 United States Pertuzumab Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pertuzumab Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Human Source
  1.2.4 Animal Source
1.3 United States Pertuzumab Market by Application/End Users
  1.3.1 United States Pertuzumab Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 United States Pertuzumab Market by Region
  1.4.1 United States Pertuzumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pertuzumab Status and Prospect (2012-2022)
  1.4.3 Southwest Pertuzumab Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pertuzumab Status and Prospect (2012-2022)
  1.4.5 New England Pertuzumab Status and Prospect (2012-2022)
  1.4.6 The South Pertuzumab Status and Prospect (2012-2022)
  1.4.7 The Midwest Pertuzumab Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pertuzumab (2012-2022)
  1.5.1 United States Pertuzumab Sales and Growth Rate (2012-2022)
  1.5.2 United States Pertuzumab Revenue and Growth Rate (2012-2022)

2 UNITED STATES PERTUZUMAB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pertuzumab Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pertuzumab Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pertuzumab Average Price by Players/Suppliers (2012-2017)
2.4 United States Pertuzumab Market Competitive Situation and Trends
  2.4.1 United States Pertuzumab Market Concentration Rate
  2.4.2 United States Pertuzumab Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pertuzumab Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PERTUZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pertuzumab Sales and Market Share by Region (2012-2017)
3.2 United States Pertuzumab Revenue and Market Share by Region (2012-2017)
3.3 United States Pertuzumab Price by Region (2012-2017)

4 UNITED STATES PERTUZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pertuzumab Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pertuzumab Revenue and Market Share by Type (2012-2017)
4.3 United States Pertuzumab Price by Type (2012-2017)
4.4 United States Pertuzumab Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PERTUZUMAB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pertuzumab Sales and Market Share by Application (2012-2017)
5.2 United States Pertuzumab Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PERTUZUMAB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pertuzumab Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Pertuzumab Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abnova Corporation
  6.3.2 Pertuzumab Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abnova Corporation Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 InvivoGen
  6.4.2 Pertuzumab Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 InvivoGen Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Celltrion
  6.5.2 Pertuzumab Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celltrion Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biocon Limited
  6.6.2 Pertuzumab Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biocon Limited Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Techne
  6.7.2 Pertuzumab Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Techne Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PERTUZUMAB MANUFACTURING COST ANALYSIS

7.1 Pertuzumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pertuzumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pertuzumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pertuzumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PERTUZUMAB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pertuzumab Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pertuzumab Sales Volume Forecast by Type (2017-2022)
11.3 United States Pertuzumab Sales Volume Forecast by Application (2017-2022)
11.4 United States Pertuzumab Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pertuzumab
Figure United States Pertuzumab Market Size (K Pcs) by Type (2012-2022)
Figure United States Pertuzumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Source Product Picture
Figure Animal Source Product Picture
Figure United States Pertuzumab Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Pertuzumab by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure United States Pertuzumab Market Size (Million USD) by Region (2012-2022)
Figure The West Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pertuzumab Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pertuzumab Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Pertuzumab Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Pertuzumab Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pertuzumab Sales Share by Players/Suppliers
Figure 2017 United States Pertuzumab Sales Share by Players/Suppliers
Figure United States Pertuzumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pertuzumab Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pertuzumab Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pertuzumab Revenue Share by Players/Suppliers
Figure 2017 United States Pertuzumab Revenue Share by Players/Suppliers
Table United States Market Pertuzumab Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Pertuzumab Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Pertuzumab Market Share of Top 3 Players/Suppliers
Figure United States Pertuzumab Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pertuzumab Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pertuzumab Product Category
Table United States Pertuzumab Sales (K Pcs) by Region (2012-2017)
Table United States Pertuzumab Sales Share by Region (2012-2017)
Figure United States Pertuzumab Sales Share by Region (2012-2017)
Figure United States Pertuzumab Sales Market Share by Region in 2016
Table United States Pertuzumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pertuzumab Revenue Share by Region (2012-2017)
Figure United States Pertuzumab Revenue Market Share by Region (2012-2017)
Figure United States Pertuzumab Revenue Market Share by Region in 2016
Table United States Pertuzumab Price (USD/Pcs) by Region (2012-2017)
Table United States Pertuzumab Sales (K Pcs) by Type (2012-2017)
Table United States Pertuzumab Sales Share by Type (2012-2017)
Figure United States Pertuzumab Sales Share by Type (2012-2017)
Figure United States Pertuzumab Sales Market Share by Type in 2016
Table United States Pertuzumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pertuzumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pertuzumab by Type (2012-2017)
Figure Revenue Market Share of Pertuzumab by Type in 2016
Table United States Pertuzumab Price (USD/Pcs) by Types (2012-2017)
Figure United States Pertuzumab Sales Growth Rate by Type (2012-2017)
Table United States Pertuzumab Sales (K Pcs) by Application (2012-2017)
Table United States Pertuzumab Sales Market Share by Application (2012-2017)
Figure United States Pertuzumab Sales Market Share by Application (2012-2017)
Figure United States Pertuzumab Sales Market Share by Application in 2016
Table United States Pertuzumab Sales Growth Rate by Application (2012-2017)
Figure United States Pertuzumab Sales Growth Rate by Application (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Pertuzumab Sales Growth Rate (2012-2017)
Figure Novartis AG Pertuzumab Sales Market Share in United States (2012-2017)
Figure Novartis AG Pertuzumab Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Pertuzumab Sales Growth Rate (2012-2017)
Figure Pfizer Pertuzumab Sales Market Share in United States (2012-2017)
Figure Pfizer Pertuzumab Revenue Market Share in United States (2012-2017)
Table Abnova Corporation Basic Information List
Table Abnova Corporation Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Corporation Pertuzumab Sales Growth Rate (2012-2017)
Figure Abnova Corporation Pertuzumab Sales Market Share in United States (2012-2017)
Figure Abnova Corporation Pertuzumab Revenue Market Share in United States (2012-2017)
Table InvivoGen Basic Information List
Table InvivoGen Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure InvivoGen Pertuzumab Sales Growth Rate (2012-2017)
Figure InvivoGen Pertuzumab Sales Market Share in United States (2012-2017)
Figure InvivoGen Pertuzumab Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltrion Pertuzumab Sales Growth Rate (2012-2017)
Figure Celltrion Pertuzumab Sales Market Share in United States (2012-2017)
Figure Celltrion Pertuzumab Revenue Market Share in United States (2012-2017)
Table Biocon Limited Basic Information List
Table Biocon Limited Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Limited Pertuzumab Sales Growth Rate (2012-2017)
Figure Biocon Limited Pertuzumab Sales Market Share in United States (2012-2017)
Figure Biocon Limited Pertuzumab Revenue Market Share in United States (2012-2017)
Table Bio-Techne Basic Information List
Table Bio-Techne Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Techne Pertuzumab Sales Growth Rate (2012-2017)
Figure Bio-Techne Pertuzumab Sales Market Share in United States (2012-2017)
Figure Bio-Techne Pertuzumab Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pertuzumab
Figure Manufacturing Process Analysis of Pertuzumab
Figure Pertuzumab Industrial Chain Analysis
Table Raw Materials Sources of Pertuzumab Major Players/Suppliers in 2016
Table Major Buyers of Pertuzumab
Table Distributors/Traders List
Figure United States Pertuzumab Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Pertuzumab Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pertuzumab Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Pertuzumab Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pertuzumab Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pertuzumab Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Pertuzumab Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pertuzumab Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pertuzumab Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Pertuzumab Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Pertuzumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pertuzumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pertuzumab Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources